-
1
-
-
0345731430
-
Antipyretic Efficacy and Safety of Ibuprofen and Acetaminophen in Children
-
Goldman RD, Ko K, Linnett LJ, Scolnik D. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004; 38: 146-150 (Pubitemid 38018021)
-
(2004)
Annals of Pharmacotherapy
, vol.38
, Issue.1
, pp. 146-150
-
-
Goldman, R.D.1
Ko, K.2
Linett, L.J.3
Scolnik, D.4
-
2
-
-
2642584898
-
Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: A Meta-analysis
-
DOI 10.1001/archpedi.158.6.521
-
Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever, a meta-analysis. Arch Pediatr Adolesc Med 2004; 158: 521-526 (Pubitemid 38720481)
-
(2004)
Archives of Pediatrics and Adolescent Medicine
, vol.158
, Issue.6
, pp. 521-526
-
-
Perrott, D.A.1
Piira, T.2
Goodenough, B.3
Champion, G.D.4
-
3
-
-
1142310720
-
The Antipyretic Effect of Ibuprofen and Acetaminophen in Children
-
DOI 10.1592/phco.24.2.280.33138
-
Wahba H. The antipyretic effect of ibuprofen and acetaminophen in children. Pharmacotherapy 2004; 24: 280-284 (Pubitemid 38209443)
-
(2004)
Pharmacotherapy
, vol.24
, Issue.2 I
, pp. 280-284
-
-
Wahba, H.1
-
4
-
-
45749158165
-
Paediatric analgesia
-
Beggs S. Paediatric analgesia. Aust Prescr 2008; 31: 63-65
-
(2008)
Aust Prescr
, vol.31
, pp. 63-65
-
-
Beggs, S.1
-
5
-
-
52049087357
-
Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: Analysis from Phase Three of the ISAAC programme
-
Beasley R, Clayton T, Crane J, von Mutius E, Lai CK, Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039-1048
-
(2008)
Lancet
, vol.372
, pp. 1039-1048
-
-
Beasley, R.1
Clayton, T.2
Crane, J.3
Von Mutius, E.4
Lai, C.K.5
Montefort, S.6
-
6
-
-
34447121240
-
Do we need to incorporate pharmacogenetics in randomized, controlled trials of frequently used medicines?
-
van den Anker JN. Do we need to incorporate pharmacogenetics in randomized, controlled trials of frequently used medicines? Pediatrics 2007; 120: 237.
-
(2007)
Pediatrics
, vol.120
, pp. 237
-
-
Van Den Anker, J.N.1
-
7
-
-
0037108979
-
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
-
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99: 13926-13931
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 13926-13931
-
-
Chandrasekharan, N.V.1
Dai, H.2
Roos, K.L.3
Evanson, N.K.4
Tomsik, J.5
Elton, T.S.6
-
8
-
-
21344437523
-
Postoperative analgesia in infants and children
-
Lonnqvist P, Morton N. Postoperative analgesia in infants and children. Br J Anaesth 2005; 95: 59-68.
-
(2005)
Br J Anaesth
, vol.95
, pp. 59-68
-
-
Lonnqvist, P.1
Morton, N.2
-
9
-
-
11144234241
-
COX-3 and the mechanism of action of paracetamol/acetaminophen
-
DOI 10.1016/j.plefa.2004.10.005, PII S0952327804001693
-
Botting R, Ayoub S. COX-3 and the mechanism of action of paracetamol/ acetaminophen. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 85-87 (Pubitemid 40051224)
-
(2005)
Prostaglandins Leukotrienes and Essential Fatty Acids
, vol.72
, Issue.2 SPEC. ISS
, pp. 85-87
-
-
Botting, R.1
Ayoub, S.S.2
-
10
-
-
33846008062
-
Paracetamol: New vistas of an old drug
-
DOI 10.1111/j.1527-3458.2006.00250.x
-
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006; 250-275 (Pubitemid 46047791)
-
(2006)
CNS Drug Reviews
, vol.12
, Issue.3-4
, pp. 250-275
-
-
Bertolini, A.1
Ferrari, A.2
Ottani, A.3
Guerzoni, S.4
Tacchi, R.5
Leone, S.6
-
11
-
-
0036396419
-
Ontogeny of hepatic and renal systemic clearance pathways in infants: Part I
-
Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part 1. Clin Pharmacokinet 2002; 41: 959-998 (Pubitemid 35168438)
-
(2002)
Clinical Pharmacokinetics
, vol.41
, Issue.12
, pp. 959-998
-
-
Alcorn, J.1
McNamara, P.J.2
-
12
-
-
34548099546
-
Pediatric development of glucuronidation: The ontogeny of hepatic UGT1A4
-
Miyagi SJ, Collier AC. Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos 2007; 35: 1587-1592
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1587-1592
-
-
Miyagi, S.J.1
Collier, A.C.2
-
13
-
-
33750380248
-
Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations
-
Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45: 1077-1097
-
(2006)
Clin Pharmacokinet
, vol.45
, pp. 1077-1097
-
-
Bartelink, I.H.1
Rademaker, C.M.2
Schobben, A.F.3
Van Den Anker, J.N.4
-
14
-
-
70349328788
-
-
Sweetman SC, editor. 34th ed. London: Pharmaceutical Press
-
Sweetman SC, editor. Martindale: the complete drug reference. 34th ed. London: Pharmaceutical Press; 2005.
-
(2005)
Martindale: The Complete Drug Reference
-
-
-
15
-
-
11844304376
-
Clinical consequences of cytochrome P450 2C9 polymorphisms
-
DOI 10.1016/j.clpt.2004.08.009, PII S0009923604002772
-
Kirchheiner J, Brockmöller J. Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther 2005; 77: 1-16. (Pubitemid 40089477)
-
(2005)
Clinical Pharmacology and Therapeutics
, vol.77
, Issue.1
, pp. 1-16
-
-
Kirchheiner, J.1
Brockmoller, J.2
-
16
-
-
0032173110
-
Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: A case series
-
DOI 10.1016/S0002-9270(98)00365-7, PII S0002927098003657
-
Riley TR, Smith JP. Ibuprofen induced hepatotoxicity in patients with chronic hepatitis C: a case series. Am J Gastroenterol 1998; 93: 1563-1565 (Pubitemid 29075204)
-
(1998)
American Journal of Gastroenterology
, vol.93
, Issue.9
, pp. 1563-1565
-
-
Riley III, T.R.1
Smith, J.P.2
-
17
-
-
41849138252
-
Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays
-
Ambat MT, Ostrea EM Jr, Aranda JV. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays. J Perinatol 2008; 28: 287-290
-
(2008)
J Perinatol
, vol.28
, pp. 287-290
-
-
Ambat, M.T.1
Ostrea Jr., E.M.2
Aranda, J.V.3
-
18
-
-
0027244295
-
Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use
-
McIntire S, Rubenstein R, Gartner JJ, Gilboa N, Ellis D. Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use. Pediatrics 1993; 92: 459-460 (Pubitemid 23264650)
-
(1993)
Pediatrics
, vol.92
, Issue.3
, pp. 459-460
-
-
McIntire, S.C.1
Rubenstein, R.C.2
Gartner Jr., J.C.3
Gilboa, N.4
Ellis, D.5
|